Gold prices tick higher on fresh US tariff threats, Fed rate cut hopes
Investing.com - Omnicell reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Omnicell announced earnings per share of $1.00 on revenue of $348M. Analysts polled by Investing.com EPS of $0.95 on revenue of $363.24M.
Omnicell 's are down 24.15% and is trading at $60.00 , still down 59.23% from its 52 week high of $187.29 set on Monday, November 22, 2021.
Omnicell shares lost 21.42% to trade at $60.00 in pre-market trade the report.
Omnicell follows other major Healthcare sector earnings this month
Omnicell's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar